ヒドロキシクロロキンの世界市場：現状分析と予測（2022年～2028年）

世界のヒドロキシクロロキンの市場規模は、予測期間中に約10％の大幅な成長が予測されています。市場の成長は、発展途上国におけるマラリアの発生率の上昇に起因する可能性があります。

当レポートでは、世界のヒドロキシクロロキン市場について調査分析し、市場規模と予測分析、主な動向と機会、企業プロファイルなどの情報を提供しています。

目次

第1章 市場のイントロダクション

第2章 調査手法・前提条件

第3章 市場の要約

第4章 エグゼクティブサマリー

第5章 ヒドロキシクロロキン市場に対するCOVID-19の影響

第6章 ヒドロキシクロロキンの市場収益（2020年～2028年）

第7章 市場の考察：疾患別

• マラリア
• 関節リウマチ
• COVID-19
• その他

第8章 市場の考察：ドライブタイプ別

• 病院薬局
• 小売薬局
• オンライン薬局

第9章 市場の考察：地域別

• 北米
  • 米国
  • カナダ
  • その他の北米
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他の欧州
• アジア太平洋
  • 中国
  • 日本
  • インド
  • その他のアジア太平洋
• その他の地域

第10章 ヒドロキシクロロキンの市場力学

• 市場促進要因
• 市場の課題
• 影響の分析

第11章 ヒドロキシクロロキン市場の機会

第12章 ヒドロキシクロロキン市場の動向

第13章 デマンド・サプライサイド分析

• デマンドサイド分析
• サプライサイド分析

第14章 バリューチェーン分析

第15章 競合シナリオ

• 競合情勢
  • ポーターのファイブフォース分析

第16章 企業の概要

• Sanofi S.A.
• Novartis AG
• Pfizer Inc.
• Cadila Pharmaceuticals Limited
• Ipca Laboratories Limited
• Mylan N.V.
• Teva Pharmaceutical Industries Ltd.
• Torrent Pharmaceuticals Ltd.
• Sun Pharmaceutical Industries Ltd.
• Lupin Limited

第17章 免責事項

Global Hydroxychloroquine Market is expected to grow at a significant rate of around 10% during the forecast period. Hydroxychloroquine is a medicine that is sold under the brand name Plaquenil and is used for preventing and treating malaria in areas where malaria remains sensitive to chloroquine. It is also used in the treatment of rheumatoid arthritis, lupus, COVID-19, etc. The growth of the hydroxychloroquine market can be attributed to the rising incidences of malaria in developing nations. For instance, according to the World Malaria Report, in 2019, nearly 6 million individuals were diagnosed with malaria alone in India. Also, as per WHO, in 2020, there were an estimated 241 million cases of malaria worldwide and the estimated number of malaria deaths stood at 6,27,000. Furthermore, many leading manufacturers of hydroxychloroquine have escalated the production and sales of this medicine during the pandemic as different studies in France & U.S. have shown promising results for the COVID-19 treatment.

Sanofi S.A., Novartis AG, Pfizer Inc., Cadila Pharmaceuticals Limited, Ipca Laboratories Limited, Mylan N.V., Teva Pharmaceutical Industries Ltd., Torrent Pharmaceuticals Ltd., Sun Pharmaceutical Industries Ltd., Lupin Limited. are some of the key players in the market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hydroxychloroquine.

Insights Presented in the Report:

"Amongst disease, malaria category to witness robust CAGR during the forecast period"

Based on disease, the market is segmented into malaria, rheumatoid arthritis, COVID-19, and others. The malaria segment accounted for a significant market share in 2020 and it is estimated that it will grow rapidly during the projected timeframe as hydroxychloroquine is an anti-malarial drug and is widely used for treating acute attacks of malaria. Furthermore, the surging cases of malaria across the world is also one of the prominent factors contributing to the growth of the market.

"Amongst distribution channels, the hospital pharmacy to hold a significant share in the market in 2020"

On the basis of distribution channels, the market is categorized into hospital pharmacies, retail pharmacies, and online pharmacies. Among these, the hospital pharmacies to hold a significant share in the market in 2020. This is mainly due to the increasing preference of the patients to avail treatment in hospitals and the easy availability of the medication in hospital pharmacies. However, the online pharmacy segment is expected to witness significant CAGR owing to the growing penetration of e-pharmacy platforms across the world coupled with increasing awareness regarding services offered by e-pharmacy.

"Asia-Pacific to hold a significant share in the market"

For a better understanding of the market adoption of the All-Terrain Vehicle industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. APAC is anticipated to grow at a substantial CAGR during the forecast period. This is mainly due to the increasing prevalence of malaria cases in developing Asian countries. Further, India is also one of the largest manufacturers and exporters of hydroxychloroquine which is also driving the market in the region.

Reasons to buy this report:

The study includes market sizing and forecasting analysis validated by authenticated key industry experts.

The report presents a quick review of overall industry performance at one glance.

The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments.

Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.

The study comprehensively covers the market across different segments.

Deep dive regional level analysis of the industry.

Customization Options:

The global hydroxychloroquine market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

• 1.1. Market Definitions
• 1.2. Main Objective
• 1.3. Stakeholders
• 1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

• 2.1. Research Process of the Hydroxychloroquine Market
• 2.2. Research Methodology of the Hydroxychloroquine Market
• 2.3. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 IMPACT OF COVID-19 ON THE HYDROXYCHLOROQUINE MARKET

6 HYDROXYCHLOROQUINE MARKET REVENUE, 2020-2028F

7 MARKET INSIGHTS BY DISEASE

• 7.1. Malaria
• 7.2. Rheumatoid Arthritis
• 7.3. COVID-19
• 7.4. Others

8 MARKET INSIGHTS BY DRIVE TYPE

• 8.1. Hospital Pharmacy
• 8.2. Retail Pharmacy
• 8.3. Online Pharmacy

9 MARKET INSIGHTS BY REGION

• 9.1. North America
  • 9.1.1. U.S.
  • 9.1.2. Canada
  • 9.1.3. Rest of North America
• 9.2. Europe
  • 9.2.1. Germany
  • 9.2.2. U.K.
  • 9.2.3. France
  • 9.2.4. Italy
  • 9.2.5. Spain
  • 9.2.6. Rest of Europe
• 9.3. Asia-Pacific
  • 9.3.1. China
  • 9.3.2. Japan
  • 9.3.3. India
  • 9.3.4. Rest of Asia-Pacific
• 9.4. Rest of World

10 HYDROXYCHLOROQUINE MARKET DYNAMICS

• 10.1. Market Drivers
• 10.2. Market Challenges
• 10.3. Impact Analysis

11 HYDROXYCHLOROQUINE MARKET OPPORTUNITIES

12 HYDROXYCHLOROQUINE MARKET TRENDS

13 DEMAND AND SUPPLY-SIDE ANALYSIS

• 13.1. Demand Side Analysis
• 13.2. Supply Side Analysis

14 VALUE CHAIN ANALYSIS

15 COMPETITIVE SCENARIO

• 15.1. Competitive Landscape
  • 15.1.1. Porters Fiver Forces Analysis

16 COMPANY PROFILED

• 16.1. Sanofi S.A.
• 16.2. Novartis AG
• 16.3. Pfizer Inc.
• 16.4. Cadila Pharmaceuticals Limited
• 16.5. Ipca Laboratories Limited
• 16.6. Mylan N.V.
• 16.7. Teva Pharmaceutical Industries Ltd.
• 16.8. Torrent Pharmaceuticals Ltd.
• 16.9. Sun Pharmaceutical Industries Ltd.
• 16.10. Lupin Limited

17 DISCLAIMER